Malar and Sub-malar Volume Deficiency Clinical Trial
Primary end point of the study was to evaluate clinically and by non-invasive instrumental
evaluations tolerance and efficacy of a bio-revitalizing product containing hyaluronic acid
with high (H-HA) and low (L-HA) molecular weight; the micro-injection of the study product
was performed by a specialized dermatologist, bilaterally on the face (zygomatic
protuberance, nostril's angle, inferior margin of tragus, lip marionette lines, mandibular
angle) of healthy female volunteers aged 30-60 years.
It was also aim of this study to evaluate efficacy by the volunteers and tolerance both by
investigator and volunteers.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03273660 -
Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)
|
N/A |